What medicine is best for lowering blood sugar?
In recent years, diabetes has become a chronic disease with high incidence worldwide, and how to effectively control blood sugar has become the focus of patients' attention. This article will combine the hot topics and hot content on the Internet in the past 10 days to provide you with a structured analysis of the selection of antidiabetic drugs and provide data reference.
1. Classification and characteristics of common antidiabetic drugs
| drug type | Representative medicine | Mechanism of action | Applicable people |
|---|---|---|---|
| Biguanides | Metformin | Inhibit hepatic glucose output and improve insulin sensitivity | Type 2 diabetes first choice |
| Sulfonylureas | Glimepiride | Stimulates pancreatic beta cells to secrete insulin | Survivors of pancreatic islet function |
| DPP-4 inhibitors | sitagliptin | Increase incretin levels | Mild to moderate hyperglycemia |
| SGLT-2 inhibitors | empagliflozin | Promote urinary glucose excretion | People with cardiovascular disease |
| GLP-1 receptor agonists | Liraglutide | Delay gastric emptying and suppress appetite | obese diabetic patients |
2. Comparison of the efficacy of the latest anti-diabetic drugs in 2023
| Drug name | Blood sugar reduction range (HbA1c%) | weight effect | Risk of hypoglycemia | cardiovascular benefits |
|---|---|---|---|---|
| Metformin | 1.0-2.0 | lighten or neutral | low | clear |
| empagliflozin | 0.5-1.0 | alleviate | extremely low | Significantly |
| semaglutide | 1.5-2.0 | significant relief | extremely low | Significantly |
| Glezite | 1.0-1.5 | may increase | Middle to high | no clear evidence |
3. How to choose the most suitable hypoglycemic drug
1.Choose according to type of diabetes: Type 1 diabetes must use insulin; type 2 diabetes can choose oral medicine or injection preparations according to specific conditions.
2.Consider complications: Patients with cardiovascular disease are given priority to choose SGLT-2 inhibitors or GLP-1 receptor agonists; patients with kidney disease need to adjust the dose or change medications.
3.Pay attention to side effects: People with gastrointestinal tract sensitivity should use metformin with caution; elderly patients need to be alert to the risk of hypoglycemia associated with sulfonylureas.
4.economic factors: New anti-diabetic drugs are more expensive, and medical insurance reimbursement policies vary from place to place.
4. Latest suggestions from experts (updated in September 2023)
1. American Diabetes Association (ADA) guidelines still recommendMetforminAs a first-line drug for type 2 diabetes.
2. For patients with atherosclerotic cardiovascular disease (ASCVD), early use is recommendedSGLT-2 inhibitorsorGLP-1 receptor agonists.
3. Weight management has become a new focus in diabetes treatment.semaglutideGLP-1 drugs have shown significant advantages.
4. The trend of personalized treatment is obvious. It is recommended to evaluate the medication plan every 3-6 months and make timely adjustments according to changes in blood sugar.
5. Medication precautions
1. All hypoglycemic drugs should be used under the guidance of a doctor, and the dosage cannot be adjusted by yourself.
2. Monitor blood sugar and HbA1c regularly to evaluate drug efficacy.
3. Pay attention to drug interactions, especially when using multiple antidiabetic drugs at the same time.
4. The best results can be achieved with lifestyle intervention (diet control + exercise).
Conclusion: The selection of antidiabetic drugs needs to comprehensively consider multiple factors such as efficacy, safety, complications, and economic factors. There is no "best" drug, only the "most appropriate" solution. It is recommended that patients with diabetes visit the endocrinology department for regular follow-up visits to develop personalized blood sugar-lowering strategies.
check the details
check the details
en
